Search Results

There are 14450 results for: content related to: Performance measures in Friedreich ataxia: Potential utility as clinical outcome tools

  1. Correlation of frataxin content in blood and skeletal muscle endorses frataxin as a biomarker in Friedreich ataxia

    Movement Disorders

    Volume 26, Issue 10, 15 August 2011, Pages: 1935–1938, Wolfgang Nachbauer, Julia Wanschitz, Hannes Steinkellner, Andreas Eigentler, Brigitte Sturm, Kurt Hufler, Barbara Scheiber-Mojdehkar, Werner Poewe, Markus Reindl and Sylvia Boesch

    Article first published online : 20 JUN 2011, DOI: 10.1002/mds.23789

  2. Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis

    Acta Neurologica Scandinavica

    Volume 105, Issue 3, March 2002, Pages: 164–168, T. Patzold, M. Schwengelbeck, L.-M. Ossege, J.-P. Malin and E. Sindern

    Article first published online : 8 MAR 2002, DOI: 10.1034/j.1600-0404.2002.1o135.x

  3. You have free access to this content
    Diabetes in Friedreich Ataxia

    Journal of Neurochemistry

    Volume 126, Issue s1, August 2013, Pages: 94–102, Miriam Cnop, Hindrik Mulder and Mariana Igoillo-Esteve

    Article first published online : 17 JUL 2013, DOI: 10.1111/jnc.12216

  4. Antioxidants and other pharmacological treatments for Friedreich ataxia

    Intervention Review

    The Cochrane Library

    Mary Kearney, Richard W Orrell, Michael Fahey and Massimo Pandolfo

    Published Online : 18 APR 2012, DOI: 10.1002/14651858.CD007791.pub3

  5. The reliability of the MSFC and its components

    Acta Neurologica Scandinavica

    Volume 117, Issue 6, June 2008, Pages: 421–427, E. Rosti-Otajärvi, P. Hämäläinen, K. Koivisto and L. Hokkanen

    Article first published online : 12 DEC 2007, DOI: 10.1111/j.1600-0404.2007.00972.x

  6. Use of low-dose mitozantrone to treat aggressive multiple sclerosis: a single-centre open-label study using patient self-assessment and clinical measures of multiple sclerosis status

    Internal Medicine Journal

    Volume 35, Issue 7, July 2005, Pages: 382–387, A. Ostberg, F. Pittas and B. Taylor

    Article first published online : 16 JUN 2005, DOI: 10.1111/j.1445-5994.2005.00862.x

  7. Molecular basis of Friedreich ataxia

    Movement Disorders

    Volume 16, Issue 5, September 2001, Pages: 815–821, Massimo Pandolfo

    Article first published online : 23 AUG 2001, DOI: 10.1002/mds.1162

  8. Evaluation of response of multiple sclerosis (MS) relapse to oral high-dose methylprednisolone: usefulness of MS functional composite and Expanded Disability Status Scale

    European Journal of Neurology

    Volume 15, Issue 3, March 2008, Pages: 284–288, A. M. Pascual, I. Boscá, F. Coret, M. Escutia, A. Bernat and B. Casanova

    Article first published online : 14 FEB 2008, DOI: 10.1111/j.1468-1331.2008.02061.x

  9. Spinal Cord Normalization in Multiple Sclerosis

    Journal of Neuroimaging

    Jiwon Oh, Michaela Seigo, Shiv Saidha, Elias Sotirchos, Kathy Zackowski, Min Chen, Jerry Prince, Marie Diener-West, Peter A. Calabresi and Daniel S. Reich

    Article first published online : 5 MAR 2014, DOI: 10.1111/jon.12097

  10. A0001 in Friedreich ataxia: Biochemical characterization and effects in a clinical trial

    Movement Disorders

    Volume 27, Issue 8, July 2012, Pages: 1026–1033, David R. Lynch, Steven M. Willi, Robert B. Wilson, M. Grazia Cotticelli, Karlla W. Brigatti, Eric C. Deutsch, Olena Kucheruk, William Shrader, Patrice Rioux, Guy Miller, Amale Hawi and Thomas Sciascia

    Article first published online : 28 JUN 2012, DOI: 10.1002/mds.25058

  11. FXN methylation predicts expression and clinical outcome in Friedreich ataxia

    Annals of Neurology

    Volume 71, Issue 4, April 2012, Pages: 487–497, Marguerite V. Evans-Galea, Nissa Carrodus, Simone M. Rowley, Louise A. Corben, Geneieve Tai, Richard Saffery, John C. Galati, Nicholas C. Wong, Jeffrey M. Craig, David R. Lynch, Sean R. Regner, Alicia F. D. Brocht, Susan L. Perlman, Khalaf O. Bushara, Christopher M. Gomez, George R. Wilmot, Lingli Li, Elizabeth Varley, Martin B. Delatycki and Joseph P. Sarsero

    Article first published online : 20 APR 2012, DOI: 10.1002/ana.22671

  12. Mutations in rare ataxia genes are uncommon causes of sporadic cerebellar ataxia

    Movement Disorders

    Volume 27, Issue 3, March 2012, Pages: 442–446, Brent L. Fogel, Ji Yong Lee, Jessica Lane, Amanda Wahnich, Sandy Chan, Alden Huang, Greg E. Osborn, Eric Klein, Catherine Mamah, Susan Perlman, Daniel H. Geschwind and Giovanni Coppola

    Article first published online : 27 JAN 2012, DOI: 10.1002/mds.24064

  13. Erythropoietin in Friedreich ataxia: No effect on frataxin in a randomized controlled trial

    Movement Disorders

    Volume 27, Issue 3, March 2012, Pages: 446–449, Caterina Mariotti, Roberto Fancellu, Serena Caldarazzo, Lorenzo Nanetti, Daniela Di Bella, Massimo Plumari, Giuseppe Lauria, Maria D. Cappellini, Lorena Duca, Alessandra Solari and Franco Taroni

    Article first published online : 4 JAN 2012, DOI: 10.1002/mds.24066

  14. Central role and mechanisms of β-cell dysfunction and death in friedreich ataxia–associated diabetes

    Annals of Neurology

    Volume 72, Issue 6, December 2012, Pages: 971–982, Miriam Cnop, Mariana Igoillo-Esteve, Myriam Rai, Audrey Begu, Yasmina Serroukh, Chantal Depondt, Anyishai E. Musuaya, Ihsane Marhfour, Laurence Ladrière, Xavier Moles Lopez, Dionysios Lefkaditis, Fabrice Moore, Jean-Pierre Brion, J. Mark Cooper, Anthony H. V. Schapira, Anne Clark, Arnulf H. Koeppen, Piero Marchetti, Massimo Pandolfo, Décio L. Eizirik and Françoise Féry

    Article first published online : 31 DEC 2012, DOI: 10.1002/ana.23698

  15. HFE p.C282Y heterozygosity is associated with earlier disease onset in Friedreich ataxia

    Movement Disorders

    Volume 29, Issue 7, June 2014, Pages: 940–943, Martin B. Delatycki, Geneieve Tai, Louise Corben, Eppie M. Yiu, Marguerite V. Evans-Galea, Sarah E.M. Stephenson, Lyle Gurrin, Katrina J. Allen, David Lynch and Paul J. Lockhart

    Article first published online : 3 JAN 2014, DOI: 10.1002/mds.25795

  16. Measuring the rate of progression in Friedreich ataxia: Implications for clinical trial design

    Movement Disorders

    Volume 25, Issue 4, 15 March 2010, Pages: 426–432, Lisa S. Friedman, Jennifer M. Farmer, Susan Perlman, George Wilmot, Christopher M. Gomez, Khalaf O. Bushara, Katherine D. Mathews, S. H. Subramony, Tetsuo Ashizawa, Laura J. Balcer, Robert B. Wilson and David R. Lynch

    Article first published online : 8 JAN 2010, DOI: 10.1002/mds.22912

  17. You have free access to this content
    Monitoring progression in Friedreich ataxia (FRDA): the use of clinical scales

    Journal of Neurochemistry

    Volume 126, Issue s1, August 2013, Pages: 118–124, Katrin Bürk, Stefanie R. Schulz and Jörg B. Schulz

    Article first published online : 17 JUL 2013, DOI: 10.1111/jnc.12318

  18. Clinical and Neuroimaging Assessments for Research Studies (Including Drug Trials) in Multiple Sclerosis


    Current Protocols in Neuroscience


    Michelle L. Apperson and Mark A. Agius

    Published Online : 1 JAN 2011, DOI: 10.1002/0471142301.ns1004s54

  19. Normal levels of soluble transferrin receptor in Friedreich ataxia

    Clinical Genetics

    Volume 62, Issue 3, September 2002, Pages: 250–251, K Sitte, F Zaibak, MB Delatycki and PA Ioannou

    Article first published online : 6 SEP 2002, DOI: 10.1034/j.1399-0004.2002.620312.x

  20. You have free access to this content
    Clinical measures of dysarthria in Friedreich Ataxia

    Movement Disorders

    Volume 25, Issue 1, 15 January 2010, Pages: 108–111, Arunjot Singh, Elizabeth Epstein, Lauren M. Myers, Jennifer M. Farmer and David R. Lynch

    Article first published online : 11 DEC 2009, DOI: 10.1002/mds.22776